IL 3638 (Theophylline extended-release 125 mg)

This pill with imprint "IL 3638" is Clear, Capsule-shape and has been identified as Theophylline extended-release 125 mg. It is manufactured by Inwood Laboratories Inc..

Theophylline is used in the treatment of asthma, maintenance; asthma, acute; apnea of prematurity and belongs to the drug class methylxanthines. Risk cannot be ruled out during pregnancy. Theophylline 125 mg is not a controlled substance under the Controlled Substance Act (CSA).

Theophylline extended-release

Imprint:

IL 3638

Strength:

125 mg

Color:

Clear

Shape:

Capsule-shape

Availability:

Prescription only

Drug Class:

Methylxanthines

Pregnancy Category:

C - Risk cannot be ruled out

CSA Schedule:

Not a controlled drug

Manufacturer:

Inwood Laboratories Inc.

National Drug Code (NDC):

00258-3638

Inactive Ingredients:

ferric oxide black
butylparaben
castor oil
edetate calcium disodium
ethylcellulose
gelatin
methylparaben
pharmaceutical glaze
povidone
propylparaben
sodium lauryl sulfate
sodium propionate
starch
sugar spheres
magnesium silicate

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.